N/A

Operationalizing decentralized clinical trials (DCTs) in community oncology: A thematic analysis of expert roundtable discussions.

Summary

Despite growing interest in decentralized clinical trial (DCT) methods, oncology research programs face operational, regulatory, and workforce-related barriers that may limit implementation. To better understand those challenges, the Association of Cancer Care Centers (ACCC’s) Community Oncology Research Institute (ACORI) convened a multi-stakeholder summit to identify and prioritize barriers to DCT adoption in oncology care settings.

Methods

ACORI, in partnership with the Decentralized Trials & Research Alliance (DTRA), launched a structured roundtable series to identify real-world barriers and develop scalable, practice-informed solutions. Three expert roundtables convened between November 2025 and April 2026, bringing together stakeholders from academic centers, community oncology programs, industry sponsors, federal agencies, professional societies, and advocacy organizations. Discussions focused on 3 domains: foundational barriers, real-world implementation models, and equity, scalability, and sustainability. Presenters shared. Discussions were recorded and synthesized into thematic domains through an inductive qualitative analysis.

Results

Four major themes were identified, each with associated barriers and facilitators (Table). Across all themes, successful DCT implementation depends on aligned regulatory guidance, operational readiness, intentional workforce development, and equity-centered design.

Conclusions

These findings will inform the development of an ACORI DCT Site Self-Assessment Tool and Implementation Playbook to help oncology programs assess readiness and operationalize DCT elements. ACORI will expand mentorship and peer-learning opportunities to facilitate scalable adoption of best practices across community, federal, and academic oncology settings.